A better understanding of innate responses induced by vaccination is critical for designing optimal vaccines. Here, we studied the diversity and dynamics of the NK cell compartment after prime-boost immunization with the modified vaccinia virus Ankara using cynomolgus macaques as a model. Mass cytometry was used to deeply characterize blood NK cells. The NK cell subphenotype composition was modified by the prime. Certain phenotypic changes induced by the prime were maintained over time and, as a result, the NK cell composition prior to boost differed from that before prime. The key phenotypic signature that distinguished NK cells responding to the boost from those responding to the prime included stronger expression of several cytotoxic, homing, and adhesion molecules, suggesting that NK cells at recall were functionally distinct. Our data reveal potential priming or imprinting of NK cells after the first vaccine injection. This study provides novel insights into prime-boost vaccination protocols that could be used to optimize future vaccines.
INTRODUCTION
A better understanding of the early events following vaccination is critical for identifying key biomarkers and mechanisms involved in the subsequent establishment of immune memory to optimize future vaccines. 1 This requires extensive characterization of the vaccineinduced innate immune response.
NK cells are innate lymphoid cells that can constitutively kill cells
carrying an abnormal MHC signature, via interactions of activating and Abbreviations: CBC, complete blood count; DC, dendritic cell; LASSO, least absolute shrinkage and selection operator; LDA, linear discriminant analysis; MCMV, mouse cytomegalovirus; MSI, mean signal intensity; MVA, modified vaccinia virus Ankara; NHP, nonhuman primates; SPADE, spanning-tree progression analyses of density-normalized events inhibitory receptors between NK cells and their targets. [2] [3] [4] The wide diversity of the NK cell receptor repertoire implies a large range of potential NK cell subpopulations. 5 NK cells exhibit numerous functions other than cytotoxicity, including modulation of the behavior of other innate and adaptive immune cell populations, such as through crosstalk with dendritic cells (DCs) or cytokine production. [6] [7] [8] [9] [10] In particular, NK cells strongly interact with DCs, resulting in the activation of both cell types. 11, 12 Also, NK cells were shown to orientate the B cell response and the underlying affinity maturation via the restriction of follicular helper T cells, a feature that is key in the generation of broadly neutralizing antibodies. 13 NK cell functions are influenced by vaccination and infection. 14, 15 In addition, recent findings in mice, macaques, and humans indicate that NK cells show adaptive-like features. [16] [17] [18] [19] However, it is not yet fully clear how these findings can be exploited to J Leukoc Biol. 2019;105:1055-1073.
c 2019 Society for Leukocyte Biologyimprove the immunogenicity and protective efficacy of vaccines. 20, 21 More studies on vaccine-induced NK cell immunity are thus admittedly required for improving vaccine design.
Modified vaccinia virus Ankara (MVA) is an attenuated vaccine derived from vaccinia virus, first developed as a vaccine against smallpox, which now serves as the vector for many recombinant vaccine candidates because of its capacity to induce strong and long-lasting immunity. 22 MVA is known to activate NK cells in mouse bone marrow and spleen, where it induces NK cell proliferation, 23 as well as in lymph nodes, where NK cells accumulate via CXCR3 signaling after being sensed by macrophages. Such recruitment is crucial for the induction of Th1 responses. 24 Moreover, the vaccine we used (MVA HIV B) was reported to prime human NK cells via NK-DC cross-talk in vitro. 25 Other studies in mice reported that NK cells are recruited to tissues in response to MVA-induced CCL2 (MCP-1) expression by macrophages. 26 We previously reported a difference in the level of CCL2 in the blood of macaques after an MVA boost relative to prime. 27 These and other studies show that MVA modulates NK cell activity and trafficking. They moreover suggest an important contribution of NK cells to MVA-induced immunity.
Nonhuman primates (NHP) are an important animal model in vaccinology, given their close immune proximity with humans, including innate immunity. 28 Immune responses in macaques to human vaccine injection are highly predictive of vaccine immunogenicity in humans.
This is particularly true for MVA. 29 Human NK cells are usually subdivided based on CD56 and CD16 expression, whereas most NK cells from macaques are CD8 + CD56 − . 30 In addition, both human and macaque NK cells express NKp46, but in macaques, NKp46 may not be expressed by all NK cell subpopulations. 28, 31 Nevertheless, close phenotypic analogies have been found between macaque and human NK cell subpopulations, and functional studies have revealed similar behavior in both species. [32] [33] [34] [35] We previously uncovered the phenotypic complexity and diversity of innate myeloid cells in the blood and the impact of vaccinations on the dynamics of their subset composition by mass cytometry 27 in cynomolgus macaques immunized with a recombinant MVA HIV-B.
We used the very same animals and a similar analytical workflow, but a 31-marker mass cytometry antibody panel dedicated to the analysis of NK cells, to determine the phenotype of blood NK cell subpopulations, as well as their diversity and evolution throughout the vaccination process.
We demonstrated a high phenotypic diversity within the blood NK cell compartment in macaques. Importantly, the study reveals the induction of changes within the NK cell subphenotype composition by the prime, some of which were maintained over time. Hence, the NK cells present at recall were different from those present at baseline. The key phenotypic signature discriminating NK cells responding to boost from those responding to prime was identified and included stronger expression of several cytotoxic, homing, and adhesion molecules.
This study has important implications for understanding the role of NK cells in vaccine-induced responses, as well as for the optimization of vaccine protocols.
MATERIALS AND METHODS

Ethics statement
The experimental protocols were approved by the ethics commit- 
Experimental design
Five male adult cynomolgus macaques, originating from Mauritius and identified as BB078, BB231, BC641, BD619, and BD620, were housed individually. Before inclusion in the study, they were tested to be negative for SIV, herpesvirus B, filovirus, STLV-1, SRV-1, SRV-2, measles virus, hepatitis B Ag, and antibodies. Regarding CMV, BB078, BB231, and BC641 were seropositive, whereas BD620 was seronegative. Animals were captive-born (first generation, F1), 7-8-year-old and weighed 8.2-10.7 kg at the beginning of the study.
Without prior selection, unbiased distribution of MHC haplotype was observed in our group of animals, with animals carrying 1 of the complete 7 common haplotypes (with H1, H2, and H3 being the most common), or recombinants, and none of them being homozygous, or matching with one another for an entire MHC haplotype.
Animals were inoculated subcutaneously with 4 × 10 8 PFU of the ANRS MVA HIV-B vaccine (MVATG17401; Transgene, IllkirchGraffenstaden, France), 36 encoding HIV-Gag (amino acids 1-519), Pol (amino acids 172-219, 325-383, and 461-519), and Nef (amino acids 66-147 and 182-206) proteins, as previously described. 27, 37 Animals were immunized 2 months apart following a homologous prime-boost strategy.
For comparison of buffer and MVA injection, 6 macaques received a subcutaneous injection with a buffer containing 10 mM Tris-HCl, saccharose 5% (w/v), 10 mM NaGlu, 50 mM NaCl, pH8.0. One month later, they were inoculated with 4 × 10 8 PFU of the ANRS MVA HIV-B vaccine. Animals were 2-5-year-old and weighed 4.9 to 6.7 kg.
Without prior selection, unbiased distribution of MHC haplotype was observed in this control group of animals, with some animals carrying 1 of the complete 7 common haplotypes or recombinants, and none of them being homozygous or matching with one another for an entire MHC haplotype.
Blood was collected in EDTA tubes for complete blood count (CBC) and whole blood flow cytometry, lithium-heparin tubes for whole blood mass cytometry analysis, and heparin cell preparation tube (CPT) (Becton Dickinson, Franklin Lakes, USA) for PBMC isolation.
Sample preparation
Fixed leukocytes were prepared for mass cytometry using a previously described cell fixation protocol, 27, 38, 39 which allows the recovery of all leukocytes, including granulocytes, from lithium-heparin whole blood.
Briefly, 1 mL of blood was incubated with a fixation buffer containing formaldehyde and glycerol for 10 min at 4 • C. After centrifugation, erythrocytes were lysed in 10 mL milli-Q water at room temperature for 20 min. Cells were then washed in 1× DPBS and stored at −80 • C at a final concentration of 15 × 10 6 cells/mL in the fixation mixture. Note that cells were fixed extemporaneously without restimulation ex vivo.
PBMCs were prepared for transcriptome analysis. Blood was collected using CPT tubes. 
Cell staining and acquisition
Fixed leukocyte staining and acquisition protocols were identical to those previously described. 27 The 31-marker antibody panel used in the present study is described in 
Data processing and event selection
FCS files were normalized with the MATLAB normalizer from Rachel
Finck et al. 41 Replicates were concatenated using the tool from Cytobank (Mountain View, USA). Leukocytes were gated based on event length, iridium content, and exclusion of nonspecifically stained CD66 + CD3 + eosinophils. 27,39
CBC and cell population count
CBCs were performed using blood collected in EDTA with the HmX instrument (Beckman Coulter). The absolute number of cells in each sample for a given cell population was computed as follows: N = the absolute number of leukocytes (expressed per L of blood) × the number of cells in the population detected by CyTOF/total number of leukocytes (excluding CD3 + CD66 + cells) detected by CyTOF (given in Table 2 ).
Identification of cell populations
The spanning-tree progression analyses of density-normalized events (SPADE) 42 algorithm was performed on the whole data set of samples Table 2 ). The quality of the SPADE clustering, defined as a narrow and unimodal distribution for each marker in all cell clusters and NK cell clusters, was assessed using the SPADEVizR R package we developed. 43 Based on these quality control measurements, SPADE was parameterized to identify 900 clusters using a downsampling of 20%, 
The number, percentage, and ID of NK cell clusters that do not reach the condition of uniformity are shown.
of CD3 − CD8 + events and contamination with CD66 low neutrophils, which displayed a low background signal in all channels including CD8.
Categorical heat map representation of NK cell clusters' phenotypes
The median expression among all samples was used to generate the categorical heat map using SPADEVizR. 43 The range of marker expression was divided into 5 categories between the 5th and the 95th percentiles to define the cell cluster phenotype. Samples containing fewer than 10 cells were removed from the median computation. Hierarchical clustering, represented by the cluster and marker dendrograms in the heat map, was performed using the Euclidean metric and the ward.D linkage method. The cluster dendrogram was used to define phenotypic families.
LASSO-LDA model to classify post-prime and post-boost NK cell immune profiles
The classification of post-prime (PP) and post-boost (PB) NK cell immune profiles was performed using a combination of the least absolute shrinkage and selection operator (LASSO) and linear discriminant analysis (LDA) methods. The LASSO method was based on the lars R package (available at https://CRAN.R-project.org/package=lars).
Abundance profiles of phenotypic families were centered and reduced.
Model validity was assessed through the leave-one-out crossvalidation method. The best configuration was chosen using the elbow criterion. Essentially, the minimum number of phenotypic families was chosen such that adding more phenotypic families did not improve the model. Graphically, this corresponds to the number of phenotypic families for which a break in slope (an "elbow") is observed when plotting the mean square error of the model as a function of the number of phenotypic families used (Supplemental Fig. S5B ). The LDA method was based on the MASS R package (available at https://CRAN.Rproject.org/package=MASS). Marker expression density distributions were compared using the CytoCompare R package 44 based on the Kolmogorov-Smirnov distance.
Validation of the LASSO-LDA model
The LASSO-LDA classifier generated using BB078, BB231, BC641, and BD620 samples was used to classify BD619 samples and validate the model. Cell cluster abundances from BD619 samples were centered and reduced with the abundance of the 4 other animals.
RNA extraction and gene-expression profiling
PBMCs were cultured overnight at 2.5 × 10 6 PBMCs/well in U-bottom 
Transcriptomic analysis
Transcriptomic signals were background corrected and quantile normalized using the limma R package (available at https://bioconductor.
org/packages/release/bioc/html/limma.html).
We identified genes associated with NK cell abundance (which is relatively low among PBMCs) by performing a two-step analysis approach. First, genes for which the expression correlated with total NK cell abundance (Pearson correlation, |R| ≥ 0.65 and P ≤ 0.05) were analyzed using the STRING database 47 to define interaction networks.
Transcriptomic data were expressed as fluorescence intensity 
Correlation between NK cell and innate myeloid cell dynamics
The Spearman correlation coefficient between the abundance (number of cells per mL) of blood NK cell phenotypic families and the abundance of blood innate myeloid cell kinetic families (groups of phenotypic families sharing similar dynamics as previously defined 27 ) was computed. The correlation was considered significant when |R| ≥ 0.6 and P ≤ 0.05.
Area under the curve
Areas under the curve (AUC) were calculated as the cumulative sum of concentrations of the population between H0 and D3 (either after prime or after boost). PP and PB AUC were compared using the permutation test from the exactRankTests R package (available at https://cran.r-project.org/web/packages/exactRankTests/index.html).
Interindividual variability
The interindividual variability in terms of phenotypic composition was quantified as the percentage of NK cells that are not classified in the same phenotypic families between 2 animals. 
Flow cytometry
Data availability
RESULTS
Total NK cell kinetics do not differ between prime and boost
We vaccinated 4 adult male cynomolgus macaques with a recombinant MVA-based vaccine following the homologous prime-boost strategy described in Fig. 1A . 27, 37 Blood samples were taken before and at various time points during the vaccination time course and fixed extemporaneously without ex vivo restimulation with the vaccine. All samples Table 2 . We then followed the analysis pipeline described in Fig. 1C . Preliminary analyses showed high interindividual variability in terms of NKG2A/C expression among NK cells, not associated with CMV serology (Supplemental Fig. S1 ).
First, we performed a SPADE analysis to identify cell populations based on the expression of the following markers: CD66abce, HLA-DR, CD3, CD107a, CD8, CD45, granzyme B, CD56, CD62L, CD4, CD11a, CD2, CD7, NKG2D, CD11c, CD69, CD25, CD16, CCR5, CXCR4, CD14, perforin, NKG2A/C, CD20, and CCR7. This strategy allowed the segregation of NK cells, defined classically for macaques as CD3 − CD8 + cells, from other leukocytes and into 33 cell clusters on a separate branch of the SPADE tree ( Fig. 2A) . Note that we notably excluded CD66 + neutrophils, HLA-DR + CD14 + monocytes, HLA-DR + CD11c + cDCs, CD3 + T cells, and HLA-DR + CD20 + B cells (Supplemental Fig. S2 ).
We analyzed the kinetics of all NK cell clusters in the blood throughout vaccination (Fig. 2B) . As expected, the number of total NK cells in the blood was relatively low (<0.5 × 10 6 cells/mL for all time points).
NK cell numbers were homogeneously affected by immunization in all animals. Indeed, NK cell numbers tended to decrease between 3 h (H3) and 6 h/1 day (H6-D1) post-immunization, both PP and PB. These changes in NK cell counts were likely to be MVA injection specific, as
shown by 6 additional control animals (Supplemental Fig. S3) . A high variability in terms of NK cell count was observed between baselines (untreated animals, before buffer injection, and before MVA injection) across the control animals (Supplemental Fig. S3A ). Buffer injection did not induce a significant early decrease in total NK cell count (P = 0.9839) (Supplemental Fig. S3B ), whereas MVA injection did (P = 0.03697) (Supplemental Fig. S3C ).
This MVA-induced decrease in NK cell count likely corresponds to NK cell recruitment to either inflamed tissues or lymphoid organs, consistent with a previous study in mice describing the recruitment of NK cells to the draining lymph node within the first day after MVA injection. 24 There were no significant differences in the NK cell dynamics between the 2 immunizations based on the comparison of PP and PB AUCs.
To further complete the picture of the NK cell response at the whole compartment level, we analyzed the gene signature associated with NK cell number using microarrays on isolated PBMCs (Fig. 3A) . There were numerous genes for which the expression correlated with NK cell abundance with a remarkably high number of gene interactions, among them, a cluster of NK cell-associated genes, such as activation/cytotoxic associated molecules (CD226, CD69, KLRK1 [NKG2D], granzyme B, and granzyme H), [50] [51] [52] [53] as well as genes encoding proteins involved in these signaling pathways (notably ITGAL/CD11a and VAV3) 54 and the chemoattractant cytokine CCL27. 55 Functional enrichment of this interacting network of genes confirmed a strong association with NK cells, which indicated that we were able to find an NK cell-associated signature within the PBMCs.
More specifically, this gene signature was associated with NK cell/DC cross-talk, NK cell cytotoxic activity, and FcR-mediated phagocytosis. To a lesser extent, this signature was associated with granulocyte diapedesis (a surprising signature, as only PBMC RNA was used) and fatty acid oxidation (Fig. 3B) . Among regulators, the most statistically significant was the IL-12 complex (Fig. 3C) , which is a well-known key cytokine in NK cell biology. 56 ESR1, LCK, CD46, and ITGAL/CD11a
were also found to be engaged. ESR1, LCK, and ITGAL/CD11a are associated with NK cell cytotoxic activity, 54,57-59 whereas CD46 is associated with complement activity. 60 We previously showed, with the very same animals, that IL-12 production was upregulated in blood neutrophils responding to the second MVA injection, as compared with those responding to the first MVA inoculation. IL-12 concentration in plasma did not differ between prime and boost though. 27 Thus, because no significant difference was found at the level of total NK cell number by contrast to IL-12 level in neutrophils, and because IL-12 signaling appeared correlated with NK cell number in blood, we further investigated whether differences could exist at a deeper phenotypic resolution of the NK cell compartment.
The NK cell compartment displays numerous subphenotypes
We used high-dimensional analysis based on marker expression intensity to investigate potential changes in NK cell phenotype after immu- is a well-known NK cell activator, 61 which was shown to potentiate the CD16 signaling cascade in vivo in humans. 62 This action was later shown to be associated with CD58 engagement on infected cells by CD2 + NK cells in vitro. 63 Also, phenotypic family 9, within superfamily C, was the only one to be CD7 mid (all other NK clusters were CD7 high ), likely related to a lower maturity. Indeed CD7 has been shown to be expressed on highly differentiated cytotoxic and cytokine-producing NK cells ex vivo in humans. 64 Moreover, 2 phenotypic families containing one single cluster displayed very peculiar phenotypes (Supplemental Fig. S4 ). Phenotypic family 8 was CD66 high , whereas other NK cell clusters were CD66 low/− , as expected. It may consist of activated NK cells that can be inhibited through CD66, as reported after homotypic CD66a interactions between melanoma and NK cells. 65 Phenotypic family 10 was HLA-DR high granzyme B low CD107a low and may correspond to "NK DCs" observed in mouse tissues 66 and ex vivo in humans. 67 
NK cell subphenotypes exhibit different kinetics
We then studied the dynamics of all identified NK cell phenotypic families ( Fig. 5A) , which, for some, contrasted with those of total NK cells (Fig. 2B) . We identified distinct and complex patterns.
The phenotypic family 7 was more highly affected by the prime than the boost (AUC comparison, P = 0.0286).
By contrast, 2 phenotypic families ( 3 and 8 ) were more highly affected by the boost than the prime (AUC comparison, P = 0.057 and 0.0286, respectively). In particular, family 3 showed a strong increase at H3PB compared with H3PP (P=0.0286).
The remaining 7 phenotypic families ( 1,2,4-6,9 , and 10 ) displayed strong interindividual variability in their dynamics and various patterns. Phenotypic family 10 notably only showed a very low peak at D14PP. Still note that for phenotypic family 5, 3 animals of 4 showed a stronger increase in number PP than PB.
Although the number of total NK cells was low throughout vaccination and essentially transiently decreased (Fig. 2B ), many NK cell subphenotypes (e.g., phenotypic families 7, 3, 5, 1, and 9) conversely showed an increase in absolute number for some time points (Fig. 5A ).
We then determined the relative abundance of the phenotypic families within each animal for each time point (Fig. 5B) . There was high interindividual diversity of the NK cell compartment relative to that of the innate myeloid cell compartment. 27 In addition, NK cell num- S5 ). This is fully consistent with the results obtained on the 6 additional control animals (Supplemental Fig. S3A ). To note, the phenotypic composition was remarkably stable within each animal between the 2 baselines (Supplemental Fig. S5 ).
Note that prior to any immunization, a high interindividual variability was observed in terms of the phenotypic composition of the NK cell compartment. Actually, on average 50 ± 6% of the NK cell compartment differs phenotypically between 2 animals (i.e.,50 ± 6% of NK cells were associated with distinct phenotypic families between The distribution of NK cell subphenotypes changed markedly throughout the prime, as early as H3PP, and dramatically between H6PP and D1PP. The major shift in the composition of the NK cell compartment remained relatively stable up to D14 (Fig. 5B) . Further changes of the subphenotype composition occurred later, between D14PP and the boost (at D58PP = H0PB). This was not observed for innate myeloid cells, for which the shift occurred essentially between D14PP and the boost. 27 One explanation is that these subphenotypes correspond to newly generated immature NK cells arising from the bone marrow, whereas all NK cells expressing homing markers, such as CCR5, CCR7, CD62L, and CXCR4 (which is indeed the case for families 3, 5, and 8, which decreased in frequencies at these time points), were previously recruited to tissues. Consistent with this hypothesis, the major phenotypic families at these time points belonged to superfamily C of poorly cytotoxic NK cells (Fig. 4) . In addition, this switch may also reflect the persistence of some poorly cytotoxic NK cells in the blood after vaccination, rather than a true increase in number or redistribution. For example, family 7 remained constant in number at D1PP but still became proportionally one of the most abundant families at this time point, because of the decrease in the numbers of the other NK cell populations ( Fig. 5A and 5B).
Overall, this analysis demonstrated that the NK cell compartment was modified by the priming immunization, and the NK cell subphenotypes' composition was not similar at H0PB relative to that at baseline. Strikingly, NK cells were mainly phenotypically highly cytotoxic at H0PB (phenotypic families 3 and 8), compared with H0PP samples where most NK cells were poorly/moderately cytotoxic ( Fig. 4 and Fig. 5B ). Note that this phenotype modification occurred before the boosting immunization and is thus independent of the boost.
We finally analyzed the diversity and dynamics of the NK cell compartment using the Simpson index as a readout (Fig. 5C ). The wide diversity of the NK cell receptor repertoire, for which each combination of NK cell receptors can virtually give rise to a new subset of NK cells, was recently uncovered. 5 However,the meaning of such NK cell diversity for vaccines is not yet understood. Admittedly, the lack of a larger set of inhibitory and activating NK receptors (which are difficult to analyze in NHP) in our antibody panel prevented us from directly addressing the issue of the NK cell repertoire, for which the diversity was previously shown to reflect immune experience. 68 Nonetheless, we were able to observe 2 distinct and complex kinetic patterns among our 4 animals (BB078 and BB231 vs. BC641 and BD620), but by no means did we detect a progressive increase in NK cell subphenotype diversity over time and after immunization.
Altogether, the mass cytometry analysis revealed that the prime induced the modification of the NK cell subphenotype composition in 2 main steps, at D1PP and between D14PP and the boost (D58PP). As a result of these phenotypic differences preexisting prior to the boost, the NK cell response differed between prime and boost.
Key phenotypic signatures between the NK cell response to prime and boost
We then aimed to define the NK cell phenotypic families that discriminate the primary and secondary NK cell responses using an approach that combined LASSO and LDA methods.
We first used the LASSO method to determine the optimal number of phenotypic families that could account for PP and PB differences (Supplemental Fig. S6 ). Based on this analysis, we chose phenotypic families 3, 8, 7, 5, and 6 that were necessary and sufficiently informative to distinguish prime and boost samples through leave-one-out cross-validation (Supplemental Fig. S6 ). These 5 phenotypic families were then used to build the LDA classification ( Fig. 6A and 6B ). The classification of PP and PB samples was correct for 31 of 33 samples (94%) and showed that phenotypic families 5 and 7 were involved with the PP response, whereas phenotypic families 3, 6, and 8 were involved with the PB response.
We further determined the phenotypic differences that distinguished NK cells that responded to the prime from those responding to the boost. We examined the mean signal intensity (MSI) of primeresponding vs. boost-responding NK cells and identified 8 markers that differed in expression intensity between the 2 signatures ( Fig.   6C and 6D ): granzyme B, CD107a, perforin, CD69, CD66abce, CCR5, CD11c, and CD16. All were more highly expressed after the boost than the prime. To a lesser extent, CD11a was also more highly expressed after the boost than the prime (Fig. 6D ). This suggests that NK cells involved with the PB immune response showed a more cytotoxic phenotype (including the ability for antibody-dependent cell cytotoxicity
[ADCC] based on CD16 expression), associated with an increased ability to traffic to lymph nodes and inflamed tissues. Phenotypic family 5, which was involved in the PP response, also belonged to superfamily A of highly cytotoxic NK cells, together with phenotypic families 3 and 8 (Fig. 4) . However, it displayed a higher CCR5 expression and lower levels of CD2, CD7, CD16, and CD11a than the PB highly cytotoxic NK cells from phenotypic families 3 and 8, suggesting a stronger ability to traffic to inflamed tissues, while simultaneously showing a less mature/activated phenotype. This observation is consistent with the fact that NK cells responding to the boost showed a more cytotoxic (and potentially more mature) phenotype in the blood than those responding to the prime.
Validation of the phenotypic signature distinguishing NK responses to prime and boost
To validate the results and model obtained on samples from 4 animals, we used 4 samples from a fifth animal from the same cohort, macaque BD619, which was not included in the previous steps of the analysis.
After associating each cell with the SPADE cluster it was the closest to, we were able to define the phenotypic composition of these samples with respect to our SPADE analysis (Fig. 7A ). BD619 showed a phenotypic signature fairly consistent with the 4 animals used to build the model, with a high abundance of phenotypic families 7 and 9 at H3PP, H6PP, and D1PP, a high abundance of phenotypic families 2 and 4 at D1PP and D1PB, and high abundance of phenotypic family 3 at D1PB. (which obtained a low PB score), the time point for which the model already misclassified the BC641 sample. This misclassification is due to the relatively high abundance of family 8 at H6PP for these 2 animals, while family 8 is overall more enriched after the boost and was used as such in the LDA classifier.
In conclusion, applying our SPADE analysis and resulting LDA generated from "only" 4 animals (but 39 samples) on those previously unseen samples gave consistent results and strengthened the definition of our NK cell signature to prime and boost.
The NK cell response correlates with the innate myeloid response
We further investigated how the NK cell response integrated with the innate myeloid response to MVA. We previously reported, in the same animals, that neutrophils, monocytes, and cDCs responded differently to the priming and boosting immunization. Some subphenotypes were enriched only after 1 of the 2 immunizations, with cells responding to the boost expressing higher levels of markers involved in phagocytosis, Ag presentation, costimulation, chemotaxis, and inflammation. 27 Here,
we assessed the correlation between the dynamics of NK cell subphenotypes and those of these innate myeloid cell subphenotypes, based on cell abundance (Fig. 8) .
The abundance of NK cells responding to the prime inversely cor- 
DISCUSSION
We previously reported that vaccination elicits a distinct innate myeloid immunity between prime and after boost. 27 Using the very same animals, we show here that, NK cell immune responses also differ between each immunization. In contrast to the myeloid response, blood NK cell dynamics were driven mainly by decreases in cell number, and there was wider interindividual variability. We have previously documented a transient decrease of NK cell numbers in the blood after intradermal MVA injection in macaques. 46 In contrast to total NK cells, some NK cell subphenotypes increased in number after immunization, with some showing a differential enrichment after the prime and boost. More strikingly, our study revealed that some modifications of NK cell subphenotype composition toward a more mature and cytotoxic phenotype were induced by the prime. These changes occurred in 2 steps: a first early and quite long-lasting shift in phenotype (from D1PP and maintained up to D14PP), followed by a later one (between D14PP and D58PP). As a core result of these phenotypic changes, the NK cell composition before the prime and prior to the boost differed, and the NK cells responding to the boost were phenotypically more mature/cytotoxic.
There are numerous terminologies used in the literature to describe distinct NK cell subpopulations displaying memory-like
Intercorrelation between NK cell and innate myeloid cell immune responses. Correlations between the abundance of NK and innate myeloid cell subphenotypes 27 were computed using the Spearman method. Correlations with |R| ≥ 0.6 and P ≤ 0.05 are represented by green (R ≥ 0.6) and purple (R ≤ 0.6) lines joining the indicated subphenotypes. LASSO/LDA was used to discriminate PP (blue) and PB (red) NK cell ( Fig. 6A ) and innate myeloid cell subphenotypes. 27 Subphenotypes not necessary for the classification are shown in black features including but not limited to Ag-specific NK cells, [17] [18] [19] 69 cytokine-induced NK cells, 18, 19 cytokine-activated NK cells, 69 liverrestricted NK cells, 19 memory-like NK cells, 18 or adaptive NK cells. 18 Many of these data were obtained in patients or animals infected by the cytomegalovirus. To our knowledge, there is not yet a clear consensus on the phenotype of these different subpopulations of NK cells, although some markers seem to be important, such as Ly49H and KLRG1 in mice or NKG2C and CD57 in humans. 19, 69 Due to a lack of reactivity with fixed macaque cells of antibodies targeting many of NK receptors (such as NKp80, NKp46, NKp30, and CD158a), as well as CD57, those markers could not be included in our analyses, and available antibodies could not distinguish between NKG2A and NKG2C in macaques. In the present study, the main argument for induction of memory-like NK cells is the emergence or preponderance of some particular NK subphenotypes and overall their persistence long after MVA prime (2 months). Whether these MVA prime-induced NK cells correspond to memory-like NK cells, and which one (cytokine-induced or Ag-specific), remain to be fully tested with functional assays and transcriptional profiling approaches.
In addition, these missing markers may impair the capture of the whole NK cell diversity and explain why our LDA classifier was less efficient when dealing with NK cell subpopulation to distinguish PP and PB samples than the LDA generated on innate myeloid cell subpopulations, 27 despite strong correlations between NK cell and innate myeloid cell response at the boost.
Besides, we noticed a high interindividual variability in NK cell counts and phenotypes at steady state, prior to any immunization, We used mass cytometry to identify key markers that clearly distinguish the NK cell immune response to the prime from that to the boost. 76 This strongly suggests that live, replication-competent microorganisms are likely to be more efficient at priming innate immune memory. Several hypotheses could explain the discrepancies between these results in mice and ours, apart from the simple difference between animal models. Indeed, different routes of injection may differentially influence systemic immunity. For example, previous studies on trained immunity showed that intravenous, but not subcutaneous, injection of BCG-induced stem cells gave rise to trained myeloid progeny. 77 The impact that the route of injection could have on NK cell responses is still largely unaddressed. 21 Another explanation is that the authors focused on the NK cell compartment 6 months after priming, without analyzing intermediate time points. It is possible that the primed NK cells we observed in our setting may be only short-lived and would vanish in the long term in the absence of boosting.
Another question is whether those primed NK cells were Agspecific (and in this case MVA or HIV) or not. Indeed, one may wonder to which extent these phenotypically modified NK cells provided crossprotection to a wide range of pathogens, as for trained innate myeloid cells 78 or whether they would be restricted to some specific Ags. 18 Indeed, should they be Ag-specific, they would respond differently to the boost only if the correct Ag is present in the boosting immunization.
Should they be non-Ag-specific (cytokine-induced memory NK cells), they would likely respond differently irrespective of the boost. Further functional studies will be required to firmly conclude on Ag specificity.
Strikingly, CD16, CCR5, and, to a lesser extent, CD11a were more highly upregulated on NK cells after the boost than the prime, similarly to monocytes, DCs, and neutrophils. 27 This indicates that (i) these features are shared by both lymphoid and myeloid innate cells and (ii) one consequence of a boost is more consistent CCR5 upregulation, which is likely linked to tissue recruitment. However, the innate myeloid and NK cell responses were clearly distinct, with innate myeloid cells being rapidly enriched after immunization, whereas NK cell numbers decreased. In addition, the kinetics of subphenotype composition modifications induced by the prime differed between NK and innate myeloid cells. This suggests that the mechanisms behind the training of innate lymphoid and myeloid immune cells differ.
We found strong correlations between NK cell and innate myeloid cell responses. Responses to the boost clearly correlated between the 2 compartments. Similarly, the innate myeloid response to the boost negatively correlated with that of the NK cells to the prime. In contrast, the innate myeloid response to the prime did not correlate with that of the NK cells to the prime, neither did it negatively correlate with the NK cell response to the boost. Overall, this suggests that the innate response to the boost is more coordinated between NK cells and innate myeloid cells than the response to the prime. Whether this is the result of a more efficient cross-talk between NK cells and myeloid cells after the boost than after the prime is yet to be addressed.
Finally, addressing whether some features of the NK cell response correlate with the adaptive immune response and how this could be used to better predict the establishment of immune memory is still a challenge. Also, further investigating NK cell responses in tissues other than blood is another challenge that will need to be met to obtain a fully comprehensive picture of the vaccine-induced NK cell response.
To our knowledge, this is the first study using CyTOF technology for the longitudinal analysis of NK cells after vaccination. It revealed key features of NK cell phenotype after immunization and without any ex vivo restimulation with the vaccine, in contrast to other studies analyzing the "recall" NK cell response. 8, 79, 80 This work aims to pave the way for future studies aiming to exploit this knowledge to optimize future vaccine. 
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